|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
|---|---|
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00090506 |
Purpose
The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.
| Condition | Intervention | Phase |
|---|---|---|
|
HIV Infections Diabetes Depression |
Behavioral: Yoga |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Yoga, Health, and Meditation |
| Estimated Enrollment: | 50 |
| Study Start Date: | July 2004 |
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.
Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.
Eligibility| Ages Eligible for Study: | 14 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria for Study 1 Participants:
Inclusion Criteria for Study 2 Participants:
Inclusion Criteria for All Participants:
Exclusion Criteria for Study 2 Participants:
Contacts and Locations More Information
| Study ID Numbers: | R21 AT001942-01 |
| Study First Received: | August 26, 2004 |
| Last Updated: | January 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00090506 History of Changes |
| Health Authority: | United States: Federal Government |
|
Yoga Meditation |
|
Sexually Transmitted Diseases, Viral Metabolic Diseases Depression Acquired Immunodeficiency Syndrome Diabetes Mellitus Endocrine System Diseases Depressive Disorder Immunologic Deficiency Syndromes Behavioral Symptoms |
Virus Diseases HIV Infections Mental Disorders Sexually Transmitted Diseases Mood Disorders Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder Retroviridae Infections |
|
RNA Virus Infections Sexually Transmitted Diseases, Viral Metabolic Diseases Slow Virus Diseases Depression Immune System Diseases Acquired Immunodeficiency Syndrome Diabetes Mellitus Endocrine System Diseases Infection Depressive Disorder |
Immunologic Deficiency Syndromes Behavioral Symptoms Virus Diseases Mental Disorders HIV Infections Sexually Transmitted Diseases Mood Disorders Lentivirus Infections Glucose Metabolism Disorders Retroviridae Infections |
